Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Infliximab

Brand: Remicade┬«, Inflectra┬«, Remsima┬«
NICE TA: 
Indication: Second line in psoriatic arthritis (PsA) following discontinuation of first anti-TNF due to an adverse event or primary or secondary inefficacy .
Disease category: Musculoskeletal and joint diseases
Commissioning responsibility: CCG
PbR excluded: Yes

Background

Recommendation

LMMG recommendation: Red
Click here to find the definitions for the colour classifications

Reason for decision:  Specialist medicine

Supporting documents:

Biosimilars of Infliximab (Version 1.1) (271.7 KiB)

Psoriatic Arthritis Recommended Treatment Pathway (Version 1.0) (320.0 KiB)

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG

Red

Red